Carregant…
Dendritic cell-based immunotherapy in ovarian cancer
Worldwide, 80% of patients with ovarian cancer die of the disease. New treatments for this aggressive disease are therefore being intensively searched. Although dendritic cell-based vaccines against gynecological malignancies are in their infancy, this immunotherapeutic approach holds much promise....
| Autors principals: | , , |
|---|---|
| Format: | Online Article Text |
| Idioma: | English |
| Publicat: |
Landes Bioscience
2013
|
| Matèries: | |
| Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913669/ https://www.ncbi.nlm.nih.gov/pubmed/24501688 http://dx.doi.org/10.4161/onci.27059 |